Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

Neurocrine Clinical Site, Sofia

Neurocrine Clinical Site, Vratsa

Neurocrine Clinical Site, Plovdiv

Neurocrine Clinical Site, Veliko Tarnovo

Neurocrine Clinical Site, Rousse

Neurocrine Clinical Site, Varna

Neurocrine Clinical Site, Tsarev Brod

Neurocrine Clinical Site, Stockholm

Neurocrine Clinical Site, Gaithersburg

Neurocrine Clinical Site, Lund

Neurocrine Clinical Site, Kladno

Neurocrine Clinical Site, Pilsen

Neurocrine Clinical Site, Halmstad

Neurocrine Clinical Site, Palmetto Bay

Neurocrine Clinical Site, Birmingham

Neurocrine Clinical Site, Huntsville

Neurocrine Clinical Site, Memphis

Neurocrine Clinical Site, Katowice

Neurocrine Clinical Site, Gothenburg

Neurocrine Clinical Site, Columbus

Neurocrine Clinical Site, North Canton

Neurocrine Clinical Site, Weldon Spring

Neurocrine Clinical Site, Oklahoma City

Neurocrine Clinical Site, Dallas

Neurocrine Clinical Site, Houston

Neurocrine Clinical Site, Draper

Neurocrine Clinical Site, Torrance

Neurocrine Clinical Site, Trenčín

Neurocrine Clinical Site, San Diego

Neurocrine Clinical Site, Riverside

Neurocrine Clinical Site, San Francisco

Neurocrine Clinical Site, Rimavská Sobota

Neurocrine Clinical Site, Hartford

Neurocrine Clinical Site, Prague

Neurocrine Clinical Site, Prague

Neurocrine Clinical Site, Prague

Neurocrine Clinical Site, Bełchatów

Neurocrine Clinical Site, Chełmno

Neurocrine Clinical Site, Gdansk

Neurocrine Clinical Site, Košice

Neurocrine Clinical Site, Vranov nad Topľou